- Home
- BON vs TCRT Comparison
BON vs TCRT Comparison
Compare BON & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BON
- TCRT
- Stock Information
- Founded
- BON 2006
- TCRT 1998
- Country
- BON China
- TCRT United States
- Employees
- BON N/A
- TCRT N/A
- Industry
- BON Medicinal Chemicals and Botanical Products
- TCRT Biotechnology: Pharmaceutical Preparations
- Sector
- BON Health Care
- TCRT Health Care
- Exchange
- BON Nasdaq
- TCRT Nasdaq
- Market Cap
- BON 7.9M
- TCRT 7.0M
- IPO Year
- BON 2021
- TCRT N/A
- Fundamental
- Price
- BON $1.83
- TCRT $2.66
- Analyst Decision
- BON
- TCRT
- Analyst Count
- BON 0
- TCRT 0
- Target Price
- BON N/A
- TCRT N/A
- AVG Volume (30 Days)
- BON 104.3K
- TCRT 1.3M
- Earning Date
- BON 01-30-2026
- TCRT 11-14-2025
- Dividend Yield
- BON N/A
- TCRT N/A
- EPS Growth
- BON N/A
- TCRT N/A
- EPS
- BON 2.46
- TCRT N/A
- Revenue
- BON $21,610,848.00
- TCRT $6,000.00
- Revenue This Year
- BON $223.38
- TCRT $5,680,500.00
- Revenue Next Year
- BON $18.82
- TCRT N/A
- P/E Ratio
- BON $0.75
- TCRT N/A
- Revenue Growth
- BON N/A
- TCRT N/A
- 52 Week Low
- BON $1.14
- TCRT $1.31
- 52 Week High
- BON $73.75
- TCRT $6.20
- Technical
- Relative Strength Index (RSI)
- BON 43.02
- TCRT 45.53
- Support Level
- BON $1.88
- TCRT $2.62
- Resistance Level
- BON $2.07
- TCRT $2.79
- Average True Range (ATR)
- BON 0.13
- TCRT 0.20
- MACD
- BON -0.03
- TCRT -0.07
- Stochastic Oscillator
- BON 9.26
- TCRT 13.52
About BON Bon Natural Life Limited
Bon Natural Life Ltd is engaged in the manufacturing of personal care ingredients, such as plants extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. Xi'an App-Chem is devoted to providing high quality and competitive prices and a stable supply of products and services for the functional food, personal care, natural medicine and other industries. It provides these products and services for third party customers, as well as for its own proprietary brands. The company has its geographic presence in PRC and in Overseas. The company derives maximum revenue from Bioactive food ingredients.
About TCRT Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations. It has a single reportable and operating segment related to biopharmaceutical research and development.